1. Wu, Xianqiu, Wang, Bin, Su, Yaorong, Ren, Dong, Li, Chao. 2022. ALG8 Fuels Stemness Through Glycosylation of the WNT/Beta-Catenin Signaling Pathway in Colon Cancer. In DNA and cell biology, 41, 1075-1083. doi:10.1089/dna.2022.0165. https://pubmed.ncbi.nlm.nih.gov/36454274/
2. Boerrigter, Melissa M, Te Morsche, René H M, Venselaar, Hanka, Hoorens, Anne, Drenth, Joost P H. 2023. Novel α-1,3-Glucosyltransferase Variants and Their Broad Clinical Polycystic Liver Disease Spectrum. In Genes, 14, . doi:10.3390/genes14081652. https://pubmed.ncbi.nlm.nih.gov/37628703/
3. Yu, Chih-Chuan, Lee, An-Fu, Kohl, Stefen, Hildebrandt, Friedhelm, Hwang, Daw-Yang. 2022. PKD2 founder mutation is the most common mutation of polycystic kidney disease in Taiwan. In NPJ genomic medicine, 7, 40. doi:10.1038/s41525-022-00309-w. https://pubmed.ncbi.nlm.nih.gov/35778421/
4. Vesela, K, Honzik, T, Hansikova, H, Hennet, T, Zeman, J. 2009. A new case of ALG8 deficiency (CDG Ih). In Journal of inherited metabolic disease, 32 Suppl 1, . doi:10.1007/s10545-009-1203-z. https://pubmed.ncbi.nlm.nih.gov/19688606/
智鼠故事 
